This trend suggests a cumulative risk associated with aging and supports prior literature linking age-related multimorbidity and polypharmacy with increased exposure to anticholinergic medications.[ 18 , 19 ] Interestingly, although older patients had higher mean ACB scores, the differences in categorical ACB risk classifications between age groups did not reach statistical significance.
← all excerpts
Anticholinergic burden and polypharmacy in hospitalized urology patients: Prevalence and clinical implications.
1
—
—